14 min
SAINT TMS Cleared for Treatment-Resistant Depression The Carlat Psychiatry Podcast
-
- Mental Health
On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.CME: Podcast CME Post-Tests are available using this subscription (https://www.thecarlatreport.com/product/carlat-psychiatry-podcast-cme-subscription/). If you have already enrolled in that program, please log in (https://www.thecarlatreport.com/my-account/).Published On: 09/12/22Duration: 14 minutes, 00 seconds
On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.CME: Podcast CME Post-Tests are available using this subscription (https://www.thecarlatreport.com/product/carlat-psychiatry-podcast-cme-subscription/). If you have already enrolled in that program, please log in (https://www.thecarlatreport.com/my-account/).Published On: 09/12/22Duration: 14 minutes, 00 seconds
14 min